Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Besser

Showing results (461-470 of 828) with videos related to

Pageof 83
Sort By:
Acta Endocrinologica|October 1, 1991
Acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinemia: a double-blind studyJ A Verhelst, A L Froud, R Touzel, et al.
Clinical Endocrinology|May 1, 1985
The effect of dopamine agonist therapy on large functionless pituitary tumoursA Grossman, R Ross, M Charlesworth, et al.
Neuroendocrinology|January 1, 1987
Alpha-adrenergic stimulation of corticotropin secretion by a specific central mechanism in manS Al-Damluji, L Perry, S Tomlin, et al.
Medrxiv : the Preprint Server for Health Sciences|October 9, 2023
The Healthy Brain Initiative (HBI): A prospective cohort study protocolLilah M Besser, Stephanie Chrisphonte, Michael J Kleiman, et al.
Parkinsonism & Related Disorders|April 20, 2016
Mild cognitive impairment in Parkinson's disease versus Alzheimer's diseaseLilah M Besser, Irene Litvan, Sarah E Monsell, et al.
Clinical Endocrinology|April 1, 1986
Normal circulating immunoreactive growth hormone releasing factor (hGRF) concentrations in patients with functional hypothalamic hGRF deficiencyA M Sopwith, E S Penny, A Grossman, et al.
Clinical Endocrinology|February 1, 1983
Naloxone inhibits exercise-induced release of PRL and GH in athletesC Moretti, A Fabbri, L Gnessi, et al.
The Quarterly Journal of Medicine|September 1, 1992
Possible mechanism and treatment of o,p'DDD-induced hypercholesterolaemiaV M Maher, P J Trainer, A Scoppola, et al.
Clinical Endocrinology|October 1, 1973
Interaction between secretion of the gonadotrophins, prolactin, growth hormone, thyrotrophin and corticosteroids in man: the effects of LH FSH-RH, TRH and hypoglycaemia alone and in combinationC H Mortimer, G M Besser, A S McNeilly, et al.
Clinical Endocrinology|October 1, 1982
Opiate mediation of amenorrhoea in hyperprolactinaemia and in weight-loss related amenorrhoeaA Grossman, P J Moult, H McIntyre, et al.
Pageof 83

Showing results (461-470 of 828) with videos related to

Sort By:
Pageof 83
Acta Endocrinologica|October 1, 1991
Acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinemia: a double-blind studyJ A Verhelst, A L Froud, R Touzel, et al.
Clinical Endocrinology|May 1, 1985
The effect of dopamine agonist therapy on large functionless pituitary tumoursA Grossman, R Ross, M Charlesworth, et al.
Neuroendocrinology|January 1, 1987
Alpha-adrenergic stimulation of corticotropin secretion by a specific central mechanism in manS Al-Damluji, L Perry, S Tomlin, et al.
Medrxiv : the Preprint Server for Health Sciences|October 9, 2023
The Healthy Brain Initiative (HBI): A prospective cohort study protocolLilah M Besser, Stephanie Chrisphonte, Michael J Kleiman, et al.
Parkinsonism & Related Disorders|April 20, 2016
Mild cognitive impairment in Parkinson's disease versus Alzheimer's diseaseLilah M Besser, Irene Litvan, Sarah E Monsell, et al.
Clinical Endocrinology|April 1, 1986
Normal circulating immunoreactive growth hormone releasing factor (hGRF) concentrations in patients with functional hypothalamic hGRF deficiencyA M Sopwith, E S Penny, A Grossman, et al.
Clinical Endocrinology|February 1, 1983
Naloxone inhibits exercise-induced release of PRL and GH in athletesC Moretti, A Fabbri, L Gnessi, et al.
The Quarterly Journal of Medicine|September 1, 1992
Possible mechanism and treatment of o,p'DDD-induced hypercholesterolaemiaV M Maher, P J Trainer, A Scoppola, et al.
Clinical Endocrinology|October 1, 1973
Interaction between secretion of the gonadotrophins, prolactin, growth hormone, thyrotrophin and corticosteroids in man: the effects of LH FSH-RH, TRH and hypoglycaemia alone and in combinationC H Mortimer, G M Besser, A S McNeilly, et al.
Clinical Endocrinology|October 1, 1982
Opiate mediation of amenorrhoea in hyperprolactinaemia and in weight-loss related amenorrhoeaA Grossman, P J Moult, H McIntyre, et al.
Pageof 83